Brandinium

Trademark search for:

REXFOCAS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2021-10-28 — Application filed
  • 2021-11-01 — Application filed
  • 2021-11-09 — Application filed
  • 2022-04-10 — Teas voluntary amendment received
  • 2022-04-10 — Teas amendment entered before attorney assigned
  • 2022-08-08 — Assigned to examiner
  • 2022-08-15 — Approved for pub - principal register
  • 2022-08-31 — Notification of notice of publication e-mailed
  • 2022-09-20 — Published for opposition
  • 2022-09-20 — Official gazette publication confirmation e-mailed
  • 2022-11-15 — Noa e-mailed - sou required from applicant
  • 2022-11-30 — Attorney/dom.rep.revoked and/or appointed
  • 2022-11-30 — Teas revoke/app/change addr of atty/dom rep received
  • 2022-11-30 — Teas withdrawal of attorney received-firm retains
  • 2022-11-30 — Teas change of correspondence received
  • 2023-05-01 — Sou teas extension received
  • 2023-05-01 — Sou extension 1 filed
  • 2023-05-01 — Sou extension 1 granted
  • 2023-05-03 — Notice of approval of extension request e-mailed
  • 2023-11-13 — Sou teas extension received
  • 2023-11-13 — Sou extension 2 filed
  • 2023-11-13 — Sou extension 2 granted
  • 2023-11-15 — Notice of approval of extension request e-mailed
  • 2024-05-08 — Sou teas extension received
  • 2024-05-08 — Sou extension 3 granted
  • 2024-05-08 — Sou extension 3 filed
  • 2024-05-09 — Notice of approval of extension request e-mailed
  • 2024-12-16 — Application abandoned
  • 2024-12-16 — Application abandoned
  • 2024-12-16 — Final status recorded

Owner Information

Vertex Pharmaceuticals Incorporated
Boston , MA
Vertex Pharmaceuticals Incorporated
Boston , MA

Correspondent

Sarah Anne Keefe WOMBLE BOND DICKINSON (US) LLP
470 Atlantic Avenue, Suite 600
Boston, MA 02210-2228
United States

Filing Details

Filing Date:
2021-10-28
Status Date:
2024-12-16
Category:
Pharmaceuticals
Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.